摘要
目的研究拜耳公司世界专利产出与经济产出的相关性,揭示拜耳公司知识产权战略对于企业经济效益的影响。方法运用相关回归方法研究拜耳公司的全球专利申请数与经济产出(年销售收入/净利润)和药物研发投入的相关性,分析拜耳公司中国专利分布情况。结果拜耳公司全球专利产出与药品相关的经济收入和药物研发投入具有相关性,方差分析极具显著性。该公司在中国申请的专利以发明专利为主,专利授权率>50%。结论创新是企业利润的源泉,研发投入对创新有积极的推动作用,知识产权的保护是创新最有力的保障,拜耳公司对知识产权的重视程度直接影响其药品产业的经济效益。因此,新药创制和知识产权保护是医药企业发展的核心动力。
Objective To determine the relation between the global patent application and economic output in Bayer to understand intellectual property rights strategy for enterprise economic benefits.Methods The present study analyzed the relationship among the patent output,the economic output,the drug RD investment,and the distribution of Chinese patents in Bayer Group.Results The cumulative number of patent applications and the drug RD investment was positively related to the drug sales income in the world.Most China patents were patent of invention,with the grant ratios of invention patents more than 50.0%.Conclusion Innovation is the source of profits.RD investment plays a positive role in innovation.Protection of intellectual property is the strongest guarantee of innovation,and Bayer＇s emphasis on intellectual property directly affects the drug economic profit.New drug development and intellectual property protection are the core power of a pharmaceutical company.
出处
《中南药学》
CAS
2012年第10期776-780,共5页
Central South Pharmacy
基金
河南省知识产权软课题(No.20110602)
